PATENT CLAIM ANALYSIS

Application Number: 15743758
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["544", "106000"]

Abstract:
A compound represented by the general formula, or a salt thereof, has exceptional CXCL10 inhibitory activity and is useful as a treatment agent for the prevention and/or treatment, etc., of diseases involving overproduction of CXCL10. In the formula: R 1  is a C 1-6  alkyl group, etc.; R 2  is a hydrogen atom, etc.; R 3  is a halogen atom, etc.; Z 1 , Z 2 , and Z 3  are CH, etc.; X 1  is CONH, etc.; ring A is a phenyl group, etc.; R 4  is a halogen atom, etc.; and m is an integer of 0-5.

Claim (Index 13):
The compound according to  claim 1  or a salt thereof,\n wherein X 1  is an optionally substituted divalent cyclic hydrocarbon group resulting from the removal of one hydrogen atom from each of two adjacent atoms or an optionally substituted divalent heterocyclic group resulting from the removal of one hydrogen atom from each of two adjacent atoms.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 2.15254
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10662165', '11993652', '13463434', '15565891', '14343579']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.775767485874289
- 35 USC 102 Novelty (BERT): 0.517892094880005
- Combined Prediction Score: 0.7499799467748606
- Mean Citation Score: 298.6831059999999
- Max Citation Score: 300.6219
- Similarity Product: 220.80558228946927

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test